Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on February 19, 2010, to report its financial and operating results for the fourth quarter and full year ended December 31, 2009. The key information regarding these results was disseminated via a press release issued on February 18, 2010, which is attached as an exhibit to this filing. Investors should refer to the press release for detailed financial performance, operational achievements, and any forward-looking statements made by the company for the period.
Key Highlights
- 1Company reported its financial and operating results for the period ended December 31, 2009.
- 2The results encompass both the fourth quarter and the full fiscal year.
- 3A press release dated February 18, 2010, contains the detailed financial and operational information.
- 4The press release is furnished as an exhibit (Exhibit 99.1) to this 8-K filing.
- 5This filing serves as notification to the SEC regarding the release of the company's performance data.